To the Editor
One of us (MJS, on behalf of the authors) published an article entitled “Hypercaloric diets with high meal frequency, but not increased meal size, increase intrahepatic triglycerides: a randomized controlled trial” (1), which compared a ‘high-sugar’ (HS) vs ‘high-fat, high-sugar’ (HFHS) diet, and ‘meal frequency’ (F) vs ‘meal size’ (S) in a two-factor, randomized, controlled design. Another of us (AWB and colleagues, hereafter the readers) read the article with interest, but raised concerns about the analysis. This letter identifies clarifications that need to be made regarding those concerns.
First, there are differences in baseline values in Tables 1 and 3 in the article. These describe the same participants, and baseline values should have been identical. This is explained by the fact that Table 1 reflected data from participants with complete (meaning all study measurements) datasets only (corrected in Supplementary Table 1)..
Table 1. Between-group analysis of variance.
HFHS-S | HFHS-F | HS-S | HS-F | p | p | p | p | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Delta | SD of delta | Delta | SD of delta | Delta | SD of delta | Delta | SD of delta | overall | S vs F | HFHS vs HS | Interaction | |
BMI (kg/m2) | 0.6 | 0.6 | 0.8 | 0.5 | 0.8 | 0.3 | 0.5 | 0.6 | 0.502 | 0.655 | 0.705 | 0.165 |
REE (kcal/day) | 47 | 152 | 37 | 88 | 185 | 99 | -21 | 198 | 0.063 | 0.048 | 0.449 | 0.071 |
Glucose (mmol/l) | 0.0 | 0.5 | 0.0 | 0.2 | -0.1 | 0.3 | 0.1 | 0.3 | 0.790 | 0.453 | 0.902 | 0.540 |
Insulin (pmol/l) | 7 | 21 | 5 | 12 | 12 | 11 | -1 | 16 | 0.453 | 0.207 | 0.930 | 0.304 |
Cortisol (nmol/l) | -66 | 235 | 35 | 105 | 10 | 83 | -74 | 167 | 0.454 | 0.881 | 0.783 | 0.122 |
Glucagon (ng/l) | -10 | 23 | 4 | 19 | 9 | 13 | -8 | 25 | 0.284 | 0.849 | 0.645 | 0.059 |
Leptin (ng/ml) | 0.8 | 1.0 | 1.7 | 1.7 | 0.9 | 0.8 | 1.4 | 2.0 | 0.596 | 0.196 | 0.834 | 0.751 |
Triglycerides (mmol/l) | 0.1 | 0.5 | 0.3 | 0.2 | 0.2 | 0.3 | 0.2 | 0.4 | 0.793 | 0.488 | 0.948 | 0.485 |
FFA (mmol/l) | 0.0 | 0.1 | -0.1 | 0.2 | -0.2 | 0.2 | -0.2 | 0.3 | 0.280 | 0.278 | 0.148 | 0.485 |
EGP (umol/kg/min) | -0.1 | 1.4 | 0.2 | 1.2 | 0.0 | 1.1 | 0.4 | 1.0 | 0.886 | 0.461 | 0.789 | 0.955 |
EGP suppression (%) | 6.2 | 10.4 | -9.4† | 13.2 | -4.9 | 10.1 | 2.3 | 9.7 | 0.046 | 0.305 | 0.939 | 0.009 |
Rd (umol/kg/min) | -0.4 | 10.4 | -0.2 | 7.8 | -2.7 | 8.6 | -2.3 | 5.3 | 0.906 | 0.930 | 0.467 | 0.976 |
FFA suppression (%) | 0.0 | 9.5 | -4.6 | 4.5 | -5.4 | 9.0 | -1.2 | 5.7 | 0.431 | 0.945 | 0.706 | 0.110 |
IAAT (l) | 0.00 | 0.06 | 0.06 | 0.04 | 0.05 | 0.09 | 0.05 | 0.05 | 0.278 | 0.235 | 0.494 | 0.194 |
SQAT (l) | -0.02 | 0.05 | 0.04** | 0.03 | 0.03 | 0.04 | 0.03 | 0.02 | 0.027 | 0.066 | 0.257 | 0.035 |
VAT (l) | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | 0.06 | 0.02 | 0.03 | 1.000 | 0.985 | 0.912 | 0.985 |
IHTG content (%) | 0.2 | 0.4 | 0.4 | 0.5 | 0.1 | 0.9 | 1.6* | 1.7 | 0.028 | 0.028 | 0.132 | 0.087 |
p=0.07 vs HFHS-S with Bonferroni correction for multiple testing.
p<0.05 vs HFHS-S with Bonferroni correction for multiple testing.
p=0.06 vs HS-S with Bonferroni correction for multiple testing.
Second, we would like to clarify the between-group outcome comparisons. In Tables 3 and 4, outcomes were expressed as changes from baseline within treatments. The readers were concerned that some results were potentially consistent with the ‘differences in nominal significance’ error. This can occur when within-group changes are compared instead of between-group differences, resulting in Type I error rates up to 87.5% for four groups(2). Conclusions such as “hypercaloric diets with increased meal frequency … increase IHTG and abdominal fat in lean men whereas similar diets with increased meal size do not,” describe within-group (rather than between-group) comparisons. The authors reanalyzed the data by two-way analysis of variance of change scores (post minus pre values; Table 1). The readers did not have access to the raw data, but both agree that the results presented below add detail to the originally reported results, and show a significant overall between-group effect for suppression of endogenous glucose production (EGP suppression), subcutaneous adipose tissue (SQAT), and intrahepatic triglyceride (IHTG) content. For EGP suppression and SQAT, the interaction effect with post-hoc between-group differences between HFHS-F and HFHS-S for EGP suppression shows a trend (Bonferroni corrected p=0.07) and is significant for SQAT (Bonferroni corrected p<0.05). Finally, for IHTG there is a significant main effect of S vs F (p=0.028), as previously reported (1).
These analyses confirm the original conclusion that a hypercaloric diet with high meal frequency compared to high meal size increased IHTG. However, the conclusions that “high meal frequency increased … abdominal fat” and “snacking … contributes to obesity” should have been phrased more cautiously as the interaction effect suggests that the effect on SQAT is dependent both on the HFHS/HS factor and the F/S factor and there are no significant between-group differences for other obesity-related variables (BMI, and intraabdominal or visceral adipose tissue).
Supplementary Material
Acknowledgments
Financial Support: AWB was supported in part by NIH grant P30DK056336. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or any other organization.
Abbreviations
- EGP
Endogenous Glucose Production
- F
Meal Frequency
- HS
High-Sugar
- HFHS
High-Fat, High-Sugar
- IHTG
Intrahepatic Triglycerides
- S
Meal Size
- SQAT
Subcutaneous Adipose Tissue
Contributor Information
Mireille J Serlie, Email: m.j.serlie@amc.uva.nl.
Kasper W ter Horst, Email: k.w.terhorst@amc.uva.nl.
Andrew W Brown, Email: awbrown@uab.edu.
References
- 1.Koopman KE, Caan MW, Nederveen AJ, Pels A, Ackermans MT, Fliers E, et al. Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: a randomized controlled trial. Hepatology. 2014;60(2):545–53. doi: 10.1002/hep.27149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bland JM, Altman DG. Comparisons against baseline within randomised groups are often used and can be highly misleading. Trials. 2011;12:264. doi: 10.1186/1745-6215-12-264. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.